Doug HARTLEY United Kingdom

I am a Professor of Otology at Nottingham University and a consultant ENT surgeon at Nottingham University Hospital's NHS Trust, and Chief Medical Officer for Rinri Therapeutics. I qualified with distinction from Newcastle Medical School in 1995 and was awarded a DPhil from Oxford University in the field of hearing research in 2001. I worked as a Clinical Lecturer at Oxford University, and I was the first recipient of a Wellcome Trust Clinician Scientist Fellowship in Otolaryngology, the second across any surgical specialty. I spent time as a Surgical Fellow at the Sydney Cochlear Implant Centre, after becoming a Fellow of the Royal College of Surgeons and completing my higher surgical training in Oxford. I am the lead surgeon for the Nottingham Auditory Implant Program, one of the largest of its kind within the UK. My research team at the NIHR Nottingham Hearing Biomedical Research Centre is interested in the effects of hearing loss on the brain using functional near infrared spectroscopy and I am Chief Investigator for 2 groundbreaking UK multicenter trials in deafness (COACH and IMPACT trials). I am also employed as Chief Medical Officer for Rinri Therapeutics, leading their clinical strategy towards a first-in-human cell therapy trial for hearing loss.